Palvella Therapeutics: Qtorin Continues Making Progress, So I Remain Bullish
Source: SeekingAlpha
2026-06-05 07:30:00 ET
Read the full article on Seeking Alpha
For further details see:
Palvella Therapeutics: Qtorin Continues Making Progress, So I Remain Bullish
Palvella Therapeutics Inc.
NASDAQ: PVLA
PVLA Trading
-3.43% G/L:
$110.05 Last:
116,470 Volume:
$112 Open:
PVLA Latest News
June 03, 2026 07:30:00 am
Palvella Therapeutics Announces Completion of FDA Pre-NDA Meeting for QTORIN(TM) Rapamycin in Microcystic Lymphatic Malformations
June 02, 2026 07:30:00 am
Palvella Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026
PVLA Stock Data
$958,874,055
9,410,010
0.2%
14
N/A
Biotechnology & Life Sciences
Healthcare
US
Wayne
